Latest news
The European Union announced the completion of a pilot project validating a continuous manufacturing platform for active pharmaceutical ingredients, which integrates continuous flow chemistry, AI monitoring, and real-time analysis, and successfully produced fentanyl, offering a new pathway for future pharmaceutical production.
On August 7, 2026, Greenstone Biosciences announced receipt of a Catalyze R61 grant from NHLBI to discover novel drug candidates for myocardial fibrosis and dilated cardiomyopathy in Duchenne muscular dystrophy (DMD). The project will combine iPSC disease models, proteomics, computational screening, and generative AI; if the R61 phase is successful, it will advance to the R33 phase for in vivo testing.
Kivo announced its participation at RAPS Convergence 2026, scheduled for September 15-17 in Charlotte, N.C. The company will demonstrate Kivo Headless GxP at Booth #706, highlighting how AI agents can work alongside humans in regulated environments.
Greenstone Biosciences has received a grant from Breakthrough T1D to construct 3D islet organoids using patient-derived iPSCs, integrate multi-omics technologies to investigate mechanisms of beta cell damage in T1D, and establish a shareable cell resource repository.
Amid supply restrictions of Biltricide®, Medochemie's Bermoxel® (praziquantel 600 mg) is now available across all 27 EU member states. Manufactured by Medochemie, it is the only locally authorized supplier of praziquantel 600 mg tablets in Europe. The supply network covers Germany, Austria, the Netherlands, Belgium, Luxembourg, Greece, Cyprus, and 20 other member states.
Prefilled syringes are becoming an important innovation direction in medical drug delivery due to standardized dosing, simplified administration processes, and reduced preparation steps. Based on information released in August 2026, this article analyzes their role in patient safety, clinical efficiency, pharmaceutical packaging and manufacturing, and future development trends.
Flexcon announces the global relaunch of the PharmCal® BioMark label series for blood and plasma bags, certified by ISEGA to ensure adhesion and clarity under extreme conditions.
Young biotech companies are usually acquired rather than growing into profitable enterprises, but recently more and more companies have tried independent commercialization and succeeded.